N*AID Pr*vides $7 M*llion To M*jor *niversity To D*velop mRN* B*rd Flu ‘V*ccines’

The Duke Human Vaccine Institute has received $7 million in funding from the National Institute of Allergy and Infectious Diseases (NIAID) to develop H5N1 avian flu vaccines for use in clinical trials.

The NIAID provided the funding to Duke “under the contract called the Collaborative Influenza Vaccine Innovation Centers (CIVICs).”